Molecular Partners AG MOLN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 07/30/21 EDT
20.40quote price arrow up+0.57 (+2.85%)
Volume
5,229
52 week range
18.00 - 21.32

...

Loading . . .
  • Open20.10
  • Day High20.40
  • Day Low20.10
  • Prev Close19.83
  • 52 Week High21.32
  • 52 Week High Date07/01/21
  • 52 Week Low18.00
  • 52 Week Low Date06/16/21

Key Stats

  • Market Cap595.78M
  • Shares Out29.15M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

KEY STATS

  • Open20.10
  • Day High20.40
  • Day Low20.10
  • Prev Close19.83
  • 52 Week High21.32
  • 52 Week High Date07/01/21
  • 52 Week Low18.00
  • 52 Week Low Date06/16/21
  • Market Cap595.78M
  • Shares Out29.15M
  • 10 Day Average Volume0.02M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Molecular Partners AG

There is no recent news for this security.

Content From Our Affiliates

Profile

MORE
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical...
William Burns
Non-Executive Chairman
Patrick Amstutz Ph.D.
Chief Executive Officer
Michael Stumpp Ph.D.
Chief Operating Officer
Andreas Emmenegger
Chief Financial Officer
Address
Wagistrasse 14
Schlieren
8952
Switzerland